Case report: Neuroendocrine breast carcinoma with a germline EGFR T790M mutation
BackgroundThe epidermal growth factor receptor (EGFR) p.Thr790Met (T790M) mutation was discovered as a resistance mechanism in patients with lung cancer Headwear treated with first- and second-generation tyrosine kinase inhibitors.Further studies revealed the EGFR T790M mutation in treatment-naive non-small cell lung carcinoma (NSCLC) and as a rare